PT-141 (Bremelanotide) 10mg
$ 45.00
PT-141 (Bremelanotide) 10mg PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist studied in controlled laboratory models involving neuroendocrine signaling and melanocortin pathway activity.
Researchers investigate PT-141 for its relevance in receptor-binding studies, central signaling pathways, and melanocortin system research.
In Stock
PT-141 (Bremelanotide) 10mg PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist studied in controlled laboratory models involving neuroendocrine signaling and melanocortin pathway activity.
Researchers investigate PT-141 for its relevance in receptor-binding studies, central signaling pathways, and melanocortin system research.
Why Researchers Choose PT-141 (Bremelanotide)
Melanocortin Receptor Research
PT-141 is evaluated in models involving melanocortin receptor activity, receptor selectivity, and pathway-specific signaling.
Neuroendocrine Signaling Models
Researchers study PT-141 in controlled systems examining central nervous system signaling and neuroendocrine response markers.
Peptide Receptor Interaction Studies
Used in laboratory research focused on peptide-receptor interactions, signaling cascades, and receptor-mediated biochemical outcomes.
Pre-Clinical Research Utility
Relevant for non-clinical experimental models involving melanocortin biology and central regulatory pathways.
Reviews
Related products
